H.C. Wainwright Reiterates Buy Rating on Spruce Biosciences, Inc. (SPRB)

August 26, 2026 6:43 AM

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $150.00 price target on Spruce Biosciences, Inc. (NASDAQ: SPRB).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found